Skip to main content
. 2022 Apr 20;13:868020. doi: 10.3389/fimmu.2022.868020

Table 2.

Main outcomes by intervention groups.

A. Main outcomes by intervention group
Outcomes Regimen started
BAM/ETE CAS/IMD p-value* Total
N= 237 N= 196 N= 433
Primary Outcome a , n(%) 15 (6.3%) 4 (2.0%) 0.030 19 (4.4%)
1st Secondary Outcome b , n(%) 21 (8.9%) 8 (4.1%) 0.048 29 (6.7%)
2nd Secondary Outcome c , n(%) 9 (3.8%) 2 (1.0%) 0.068 11 (2.5%)

BAM/ETE, bamlanivimab/etesevimab; CAS/IMD, casirivimab/imdevimab.

a

Patients with COVID-19 related hospitalization or death for any cause over days 0-30.

b

Patients with hospitalization or death for any cause over days 0-30.

c

Patients with hospitalization or death for any cause over days 3-30.

*Chi-square.